Materials Map

Discover the materials research landscape. Find experts, partners, networks.

  • About
  • Privacy Policy
  • Legal Notice
  • Contact

The Materials Map is an open tool for improving networking and interdisciplinary exchange within materials research. It enables cross-database search for cooperation and network partners and discovering of the research landscape.

The dashboard provides detailed information about the selected scientist, e.g. publications. The dashboard can be filtered and shows the relationship to co-authors in different diagrams. In addition, a link is provided to find contact information.

×

Materials Map under construction

The Materials Map is still under development. In its current state, it is only based on one single data source and, thus, incomplete and contains duplicates. We are working on incorporating new open data sources like ORCID to improve the quality and the timeliness of our data. We will update Materials Map as soon as possible and kindly ask for your patience.

To Graph

1.080 Topics available

To Map

977 Locations available

693.932 PEOPLE
693.932 People People

693.932 People

Show results for 693.932 people that are selected by your search filters.

←

Page 1 of 27758

→
←

Page 1 of 0

→
PeopleLocationsStatistics
Naji, M.
  • 2
  • 13
  • 3
  • 2025
Motta, Antonella
  • 8
  • 52
  • 159
  • 2025
Aletan, Dirar
  • 1
  • 1
  • 0
  • 2025
Mohamed, Tarek
  • 1
  • 7
  • 2
  • 2025
Ertürk, Emre
  • 2
  • 3
  • 0
  • 2025
Taccardi, Nicola
  • 9
  • 81
  • 75
  • 2025
Kononenko, Denys
  • 1
  • 8
  • 2
  • 2025
Petrov, R. H.Madrid
  • 46
  • 125
  • 1k
  • 2025
Alshaaer, MazenBrussels
  • 17
  • 31
  • 172
  • 2025
Bih, L.
  • 15
  • 44
  • 145
  • 2025
Casati, R.
  • 31
  • 86
  • 661
  • 2025
Muller, Hermance
  • 1
  • 11
  • 0
  • 2025
Kočí, JanPrague
  • 28
  • 34
  • 209
  • 2025
Šuljagić, Marija
  • 10
  • 33
  • 43
  • 2025
Kalteremidou, Kalliopi-ArtemiBrussels
  • 14
  • 22
  • 158
  • 2025
Azam, Siraj
  • 1
  • 3
  • 2
  • 2025
Ospanova, Alyiya
  • 1
  • 6
  • 0
  • 2025
Blanpain, Bart
  • 568
  • 653
  • 13k
  • 2025
Ali, M. A.
  • 7
  • 75
  • 187
  • 2025
Popa, V.
  • 5
  • 12
  • 45
  • 2025
Rančić, M.
  • 2
  • 13
  • 0
  • 2025
Ollier, Nadège
  • 28
  • 75
  • 239
  • 2025
Azevedo, Nuno Monteiro
  • 4
  • 8
  • 25
  • 2025
Landes, Michael
  • 1
  • 9
  • 2
  • 2025
Rignanese, Gian-Marco
  • 15
  • 98
  • 805
  • 2025

Ruiz-Azuara, Lena

  • Google
  • 1
  • 8
  • 42

in Cooperation with on an Cooperation-Score of 37%

Topics

Publications (1/1 displayed)

  • 2017Evaluation of the binding of four anti-tumor Casiopeínas® to human serum albumin42citations

Places of action

Chart of shared publication
Correia, Isabel
1 / 3 shared
Borovic, Sladjana
1 / 1 shared
Fernandes, Luz
1 / 2 shared
Roy, Somnath
1 / 1 shared
Matos, Cristina P.
1 / 1 shared
Capelo, Jose Luis
1 / 13 shared
Pessoa, João Costa
1 / 3 shared
Santos, Hugo M.
1 / 4 shared
Chart of publication period
2017

Co-Authors (by relevance)

  • Correia, Isabel
  • Borovic, Sladjana
  • Fernandes, Luz
  • Roy, Somnath
  • Matos, Cristina P.
  • Capelo, Jose Luis
  • Pessoa, João Costa
  • Santos, Hugo M.
OrganizationsLocationPeople

article

Evaluation of the binding of four anti-tumor Casiopeínas® to human serum albumin

  • Correia, Isabel
  • Borovic, Sladjana
  • Fernandes, Luz
  • Roy, Somnath
  • Matos, Cristina P.
  • Capelo, Jose Luis
  • Ruiz-Azuara, Lena
  • Pessoa, João Costa
  • Santos, Hugo M.
Abstract

<p>The metal complexes designated by Casiopeínas® are mixed-ligand Cu<sup>II</sup>-compounds some of them having promising antineoplastic properties. We report studies of binding of Cu(glycinato)(4,7-dimethyl-1,10-phenanthroline) (Cas-II-Gly (1)), Cu(acetylacetonato)(4,7-dimethyl-1,10-phenanthroline) (Cas-III-Ea (2)), Cu(glycinato)(4,4′-dimethyl-2,2′-bipyridine) (Cas-IV-Gly (3)) and Cu(acetylacetonato)(4,4′-dimethyl-2,2′-bipyridine) (Cas-III-ia (4)) to human serum albumin (HSA) by circular dichroism (CD), Electron paramagnetic resonance (EPR) and fluorescence spectroscopy. The results indicate that HSA may bind up to three molecules of the tested Casiopeínas. This is confirmed by inductively coupled plasma – atomic absorption spectroscopy measurements of samples of HSA-Casiopeínas after passing by adequate size-exclusion columns. The binding of Cas-II-Gly to HSA was also confirmed by MALDI-TOF mass spectrometric experiments. In the physiological range of concentrations the Casiopeínas form 1:1 adducts with HSA, with conditional binding constants of ca. 1 × 10<sup>9</sup> (1), 4 × 10<sup>7</sup> (2), 1 × 10<sup>6</sup> (3) and 2 × 10<sup>5</sup> (4), values determined from the CD spectra measured, and the fluorescence emission spectra indicates that the binding takes place close to the Trp214 residue. Overall, the data confirm that these Casiopeínas may bind to HSA and may be transported in blood serum by this protein; this might allow some selective tumor targeting, particularly in the case of Cas-II-Gly. In this work we also discuss aspects associated to the reliability of the frequently used methodologies to determine binding constants based on the measurement of fluorescence emission spectra of solutions containing low concentrations of proteins such as HSA and BSA, by titrations with solutions of metal complexes.</p>

Topics
  • impedance spectroscopy
  • compound
  • experiment
  • electron spin resonance spectroscopy
  • matrix-assisted laser desorption–ionisation
  • elemental analysis
  • titration
  • fluorescence spectroscopy